Cognizant’s digital expertise is solving some of today’s most pressing challenges for pharmaceutical, biotech and medical device companies. This is an introduction to how AI, robotics, automation, IoT and other technologies can improve productivity, enhance drug safety and ensure regulatory compliancy.
Life sciences organizations are increasingly working with global partners and service providers in extended networks. How does it affect regulatory compliance?
WHO believes that 80% of all visual impairment caused by DR can be cured with early detection. Cognizant developed an AI-based diagnostic tool to help doctors.
Cognizant has helped numerous organizations across industries to achieve benefits through RPA. Among them is a major postal services organization in the Nordics.
Artificial intelligence can rapidly accelerate and improve business processes by placing customer interaction at the heart of the digital operation.
Cognizant is redefining the way life sciences companies do digital. That’s why all 30 of the top 30 global pharmaceutical companies, 9 of the top 10 biotech companies and 12 of the top 15 medical device companies work with us.
